Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)
Clinical trial NCT00060632 · COMPLETED
Trial details
- NCT number
- NCT00060632
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Primary completion
- 2005-10-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.